Defining the Utility of PET/CT in the Follow-up of Patients With Solid Tumors

Stopped early · Not applicable

Conditions studied: Cancer Recurrence, Solid Tumors

In brief

This is a comparison, at this VA Hospital,of routine multi-visit and multi-testing for solid tumor recurrence in four tumor groups to a limited scheduled 5 visit history/physical with PET/CT only, over a five year period. The purpose is to show through utilization of the single most sensitive and specific test currently available-PET/CT-that survival for patients in follow-up can be improved.(Plus lowering medical costs and increasing patient confidence and compliance with follow-up appointments).

Key facts

Study ID

NCT00954148

Run by

Dallas VA Medical Center

People needed

53

Starts

2009-09-01

Expected to finish

2010-06-01

Last updated by the study team

2010-06-30

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Completed primary therapy such that no disease is evident at the time of enrollment in the study

You may not qualify if…

• Patients unable to consent
• Without diagnosis of colorectal cancer
• Non-small cell lung cancer or squamous cell cancer of the head and neck
• Unwilling or unable to participate in the assigned follow-up program
• Having a serum glucose at time of PET/CT greater than 180mg/dl
• Stage IV disease or with evidence of disease recurrence post treatment
• Who are not a candidate for further treatment should a recurrence of disease be identified

Where it is running

• VA North Texas Health Care System — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.